Characteristics and outcomes of patients with cancer and COVID-19: results from a cohort study

Acta Oncol. 2021 Jan;60(1):24-27. doi: 10.1080/0284186X.2020.1863464. Epub 2021 Jan 5.

Authors

Alexander Höllein¹, Peter Bojko¹, Sebastian Schulz¹, Julia Neitz¹, Oliver Stötzer², Rudolf Pihusch³, Fariborz Abedinpour⁴, Burkhard Schmidt⁵, Marcus Hentrich¹

Affiliations

¹ Department of Medicine III - Hematology and Oncology, Red Cross Hospital Munich, Ludwig-Maximilians-University of Munich, Munich, Germany.
² Medical Center for Hematology and Oncology, Munich, Germany.
³ Medical Care Center Rosenheim, Rosenheim, Germany.
⁴ Departmrnt of Hematology and Oncology, Josephinum Hospital, Munich, Germany.
⁵ Practice of Hematology and Oncology Pasing, Munich, Germany.

PMID: 33397179
DOI: 10.1080/0284186X.2020.1863464

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Aged, 80 and over
COVID-19 / diagnosis
COVID-19 / epidemiology*
COVID-19 / pathology*
COVID-19 / therapy
Cohort Studies
Female
Germany / epidemiology
Hospitalization
Humans
Incidence
Male
Middle Aged
Neoplasms / epidemiology*
Neoplasms / therapy
Prognosis
SARS-CoV-2 / isolation & purification
Severity of Illness Index